drugset
drugset / Trial / NCT03586908

PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects

NCT03586908 ↗

Phase 1 Completed 24 enrolled pH Pharma
NaSingle-groupOpen-labelBasic science

Summary

An open label, multiple-dose, phase 1 clinical trial to evaluate pharmacokinetics, pharmacodynamics, safety and tolerability of PHP-201 topical eye drop in Korean and Japanese healthy subjects

Timeline

Start
2018-02-04
Primary completion
2018-02-27
Completion
2018-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AMA0076 Unknown 0.5 % Topical

Indications

No indication recorded.